These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9539719)

  • 1. Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.
    Shah AM; Kisiel W; Foster DC; Nelsestuen GL
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4229-34. PubMed ID: 9539719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1992 Jul; 267(20):14477-82. PubMed ID: 1629232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
    Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
    Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
    Bjoern S; Foster DC; Thim L; Wiberg FC; Christensen M; Komiyama Y; Pedersen AH; Kisiel W
    J Biol Chem; 1991 Jun; 266(17):11051-7. PubMed ID: 1904059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity.
    Bharadwaj D; Iino M; Kontoyianni M; Smith KJ; Foster DC; Kisiel W
    J Biol Chem; 1996 Nov; 271(48):30685-91. PubMed ID: 8940045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).
    O'Brien DP; Kemball-Cook G; Hutchinson AM; Martin DM; Johnson DJ; Byfield PG; Takamiya O; Tuddenham EG; McVey JH
    Biochemistry; 1994 Nov; 33(47):14162-9. PubMed ID: 7947828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific molecular interaction sites on factor VII involved in factor X activation.
    Kumar A; Fair DS
    Eur J Biochem; 1993 Oct; 217(2):509-18. PubMed ID: 8223595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
    Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
    Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
    Geng JP; Castellino FJ
    Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising the active site of factor VIIa above the membrane surface reduces its procoagulant activity but not factor VII autoactivation.
    Waters EK; Yegneswaran S; Morrissey JH
    J Biol Chem; 2006 Sep; 281(36):26062-8. PubMed ID: 16835245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain.
    Kavlie A; Orning L; Grindflek A; Stormorken H; Prydz H
    Thromb Haemost; 1998 Jun; 79(6):1136-43. PubMed ID: 9657438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue factor region that interacts with factor Xa in the activation of factor VII.
    Kirchhofer D; Eigenbrot C; Lipari MT; Moran P; Peek M; Kelley RF
    Biochemistry; 2001 Jan; 40(3):675-82. PubMed ID: 11170384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that an Arg79-->Gln substitution in human factor VII is not associated with a reduction in coagulant activity.
    Kazama Y; Foster DC; Kisiel W
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):697-702. PubMed ID: 1489892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residues Y179 and H101 of a hydrophobic patch of factor VII are involved in activation by factor Xa.
    Jin J; Chang J; Stafford DW; Straight DL
    Biochemistry; 2001 Sep; 40(38):11405-10. PubMed ID: 11560488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk.
    Kavlie A; Wiiger MT; Husbyn M; Stormorken H; Prydz H
    Thromb Haemost; 2004 Jan; 91(1):28-37. PubMed ID: 14691565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
    Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
    Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
    Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.